Quantcast
Last updated on April 18, 2014 at 17:24 EDT

Latest Gene expression profiling Stories

2010-05-11 07:30:00

FREMONT, Calif., May 11 /PRNewswire-FirstCall/ -- WaferGen Biosystems, Inc. (OTC Bulletin Board: WGBS), a leading developer of state-of-the-art genetic analysis systems, today announced that Alnoor Shivji, Chairman and CEO, will deliver a corporate presentation at Rodman and Renshaw's 6th Annual Global Healthcare Conference, May 18, 2010, beginning at 11:05 a.m. BST (6:05 a.m. EDT; 3:05 a.m. PDT), at the Grosvenor House Hotel, London. Mr. Shivji's presentation will cover progress with the...

2010-05-07 08:52:56

A simple genetic test that uses just three genes is among the most effective means of classifying breast cancer into sub-types, US researchers reported at the IMPAKT Breast Cancer Conference in Brussels, Belgium. The findings are a significant step in bringing more personalized treatment into breast cancer. The study is based on the already well-established fact that breast cancer is not one biologically homogeneous disease, but it is composed of several molecular sub-types each of which is...

2010-04-20 09:42:53

Hepatic fibrosis (HF) occurs in most types of chronic liver diseases and approximately 25%-40% of HF cases may ultimately progress to hepatic cirrhosis. Hepatic stellate cells (HSCs) contribute significantly to the occurrence of HF and the activation of HSC is the key issue in the pathogenesis of HF. Taurine is a kind of important anti-injury substance in the body. Taurine has a protective effect on various types of liver injury. It has been clear that the antifibrotic mechanism of taurine...

7f18f81c6e4af4506f97f813e2876aa11
2010-04-08 11:33:38

EMBL-EBI researchers present global map of human gene expression Just like members of an orchestra are active at different times although playing the same piece of music, every cell in our body contains the same genetic sequence but expresses this differently to give rise to cells and tissues with specialized properties. By integrating gene expression data from an unprecedented variety of human tissue samples, Alvis Brazma and his team at the European Bioinformatics Institute, an outstation...

2010-04-06 07:30:00

FREMONT, Calif., April 6 /PRNewswire-FirstCall/ -- WaferGen Biosystems, Inc. (OTC Bulletin Board: WGBS), a leading developer of state-of-the-art genetic analysis systems, today announced that it has named industry veteran Janet Lankard as the company's new senior vice president of worldwide sales and support in preparation for the commercialization of the WaferGen SmartChip Real-Time PCR System. "To prepare for the transition to commercialization of our SmartChip system, we are focused on...

2010-03-16 07:30:00

FREMONT, Calif., March 16 /PRNewswire-FirstCall/ -- WaferGen Biosystems, Inc. (OTC Bulletin Board: WGBS), a leading developer of state-of-the-art genetic analysis systems, today announced that Ghent University (UGent) in Belgium has signed a research collaboration and is an early-access customer for the WaferGen SmartChip(TM) Real-Time PCR System. Under the terms of the collaboration, UGent will be part of WaferGen's early-access SmartChip program with shipment occurring in the first...

2010-03-10 07:30:00

FREMONT, Calif., March 10 /PRNewswire-FirstCall/ -- WaferGen Biosystems, Inc. (OTC Bulletin Board: WGBS), a leading developer of state-of-the-art genetic analysis systems, today announced eight new early-access customers that include major universities and service providers in the U.S. and Japan. The company also announced that it has shipped the first SmartChip Real-Time PCR System to an international customer following CE marking certification. WaferGen's commercialization strategy is...

2010-03-03 07:33:00

FREMONT, Calif., March 3 /PRNewswire/ -- WaferGen Biosystems, Inc. (OTC Bulletin Board: WGBS), a leading developer of state-of-the-art genetic analysis systems, today announced that Alnoor Shivji, Chairman and CEO, will deliver a corporate presentation at the Wall Street Analyst Forum on Friday, March 12, 2010, at The University Club in New York City, at 11:20 a.m. Eastern time. The presentation will be webcast live and may be accessed at www.wafergen.com. It will be available for 90...

2010-02-16 06:00:00

- Significantly expands scope of protection for proprietary platform technology that identifies actionable biomarkers relating to disease and health from blood - TORONTO, Feb. 16 /PRNewswire-FirstCall/ - GeneNews Limited (TSX: GEN), a company focused on developing blood-based biomarker tests for the early detection of diseases and personalized health management, today announced that it has been granted a second U.S. patent for its core platform technology, the Sentinel Principle(R). U.S....

2010-02-04 07:30:00

FREMONT, Calif., Feb. 4 /PRNewswire-FirstCall/ -- WaferGen Biosystems, Inc. (OTC Bulletin Board: WGBS), a leading developer of state-of-the-art genetic analysis systems, today announced that Alnoor Shivji, Chairman and CEO, will deliver a corporate presentation at the 12th annual BIO CEO and Investor Conference in New York at The Waldorf-Astoria Hotel on Monday, February 8, 2010, at 8:30 a.m. Eastern Time. Mr. Shivji's presentation will cover the company's progress toward positioning the...